Ronald Alvarez, MD, chair of the Department of Obstetrics and Gynecology, has formed the HPV-Associated Cancer Consortium Vanderbilt (HPVACTIVE) program to raise awareness and provide community-wide education about HPV-associated cancers.
News: Head and Neck Cancer
Vanderbilt University School of Nursing (VUSN) Assistant Professor Bethany Rhoten, Ph.D., MSN, R.N., has been awarded a $30,000 grant through a Vanderbilt-Ingram Cancer Center-administered American Cancer Society pilot program to investigate the need for a self-report tool to assess sexuality in head and neck cancer patients.
Cyclic dinucleotides (CDNs) are intracellular messengers produced in bacteria that can bind to and activate an immune-mediated signaling cascade called STING in mammalian cells. CDNs have shown antitumor activity in melanoma and breast tumors. Reporting this month in the journal Head & Neck, Young J. Kim, M.D., Ph.D., associate professor of Otolaryngology at Vanderbilt University, […]
Under the microscope, they sparkle like emeralds, these molecules that may hold a key to understanding — and stopping — cancerous growth. The molecules are protein receptors that bind epidermal growth factor (EGF). Overexpression of the EGF receptor has been linked to multiple types of cancer. Drugs that block the receptor have become routine treatment […]
Tennessee has one of the lowest human papillomavirus (HPV) vaccination rates in the nation, and investigators at Vanderbilt University Medical Center (VUMC) are hoping to change this by improving the way medical providers present these vaccines to patients and by improving patient and patient family education. “HPV is the most commonly sexually transmitted infection in […]
Douglas Lowy, M.D., acting director of the National Cancer Institute (NCI), warned that worldwide death rates from cervical cancer are expected to increase in low- and middle-income countries during the next 15 years unless steps are taken to prevent the cancer from occurring. Almost all cases of cervical cancer are linked to a viral infection. […]
Nearly 39,000 new cancers associated with the human papillomavirus (HPV) will be diagnosed in the United States this year. Although HPV vaccines can prevent the majority of these cancers, vaccination rates remain low across the country. Recognizing a critical need to improve national vaccination rates for HPV, Vanderbilt-Ingram Cancer Center (VICC) is again uniting with […]
The symptoms of head and neck cancer can be subtle, so to help catch the disease in its earliest stages the Vanderbilt Department of Otolaryngology-Head and Neck Surgery and Vanderbilt-Ingram Cancer Center will offer free head and neck screenings Friday, April 15, from 9 a.m. to 3 p.m. The annual screening and educational event is […]
Contact: Dagny Stuart, (615) 936-7245 Dagny.firstname.lastname@example.org In response to low national vaccination rates for the human papillomavirus (HPV), Vanderbilt-Ingram Cancer Center (VICC) has joined 68 of the nation’s other NCI-designated cancer centers in urging increased HPV vaccination for the prevention of cancer. Experts at VICC, in collaboration with colleagues at the other cancer centers, recognize […]
Bethany Rhoten’s research focuses on issues that few people openly discuss—those surrounding body image and sexuality among cancer survivors. “While conducting research for my dissertation, I saw how difficult it is when a patient with head and neck cancer looks in the mirror and the person they see is not the person they saw six […]